Concord Biotech, Vaibhav Gems Get Approval To Launch IPOs (Public Issue)

Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.